Skip to main content

Table 2 Pathological evaluation after surgery in the two groups

From: Neoadjuvant chemoradiotherapy improves survival in locally advanced adenocarcinoma of esophagogastric junction compared with neoadjuvant chemotherapy: a propensity score matching analysis

  nCRT (n = 60, %) nCT (n = 60, %) P
R0 52 (86.7) 43 (71.7) 0.026
R1 1 (1.6) 9 (15.0)  
Non surgery 7 (11.7) 8 (13.3)  
  nCRT (n = 53, %) nCT (n = 52, %) P
pCR rate 9 (17.0) 1 (1.9) 0.030
Lymphovascular invasion 5 (9.4) 12 (23.1) 0.058
Nerval invasion 3 (5.7) 12 (23.1) 0.011
Lymph node metastasis 20 (37.7) 30 (57.7) 0.041
Node positive rate 4.4 (55/1245) 23.4 (433/1853)  < 0.001